Performance Wealth Partners LLC acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,212 shares of the financial services provider's stock, valued at approximately $2,697,000.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of CME Group by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider's stock worth $9,802,366,000 after buying an additional 588,509 shares during the period. State Street Corp raised its holdings in shares of CME Group by 0.4% in the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider's stock valued at $4,408,747,000 after buying an additional 56,725 shares during the period. Norges Bank purchased a new stake in shares of CME Group in the 4th quarter valued at $1,523,241,000. Bank of New York Mellon Corp lifted its stake in CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider's stock worth $1,344,776,000 after acquiring an additional 134,242 shares in the last quarter. Finally, Raymond James Financial Inc. lifted its stake in CME Group by 5.4% during the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider's stock worth $1,179,858,000 after acquiring an additional 222,890 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on CME shares. Barclays dropped their target price on CME Group from $316.00 to $270.00 and set an "equal weight" rating for the company in a research report on Thursday, July 9th. Rothschild & Co Redburn raised shares of CME Group from a "neutral" rating to a "buy" rating and raised their price objective for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CME Group from $342.00 to $322.00 and set a "buy" rating for the company in a report on Thursday, April 23rd. UBS Group reduced their target price on shares of CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a report on Monday, July 6th. Finally, Bank of America raised their price target on shares of CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a research report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and a consensus price target of $291.81.
Check Out Our Latest Research Report on CME
CME Group Stock Performance
Shares of CME opened at $267.88 on Tuesday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a market capitalization of $96.32 billion, a PE ratio of 22.72, a PEG ratio of 3.14 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50-day simple moving average of $250.51 and a 200-day simple moving average of $280.07.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.96 earnings per share. On average, analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's payout ratio is 44.11%.
Insider Activity at CME Group
In other CME Group news, Director William R. Shepard bought 325 shares of the company's stock in a transaction that occurred on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company's stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
